Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Scribe Therapeutics, a Nasdaq-listed clinical-stage biotech company specializing in in vivo CRISPR therapies, announced management's participation in several investor conferences in September and October 2026. The company focuses on developing genetic medicines aimed at preventing and treating cardiometabolic diseases, with its lead candidate STX-1…
Akebia Therapeutics announced that its CEO and CFO will participate in one-on-one meetings at the Wells Fargo Healthcare Conference in Boston, where they will discuss the company's commercial products and clinical-stage kidney disease pipeline.
Fervo Energy has entered a 396 MW power purchase agreement with Google for carbon-free energy from its Cape Station enhanced geothermal systems GeoCluster expected online in 2028. The agreement includes an option for Google to expand purchases to nearly 1 GW by 2030 to support a potential data center in Utah. This deal marks a significant step in d…
Cabaletta Bio, a late-stage clinical biotechnology company focused on autoimmune disease therapies, will participate in several investor conferences in September 2026, including Wells Fargo, Cantor Global Healthcare, Morgan Stanley, and H.C. Wainwright events, featuring meetings and webcasted fireside chats to update stakeholders about their clinic…
Vor Bio, a clinical-stage biotechnology company focused on treating autoimmune diseases, has announced its management team's participation in several major healthcare and biopharma investor conferences throughout September 2026. These include presentations and meetings at events hosted by Wells Fargo, Citi, Morgan Stanley, Baird, and Stifel, with l…
Enphase Energy announced that over 7,500 U.S. homeowners have enrolled in its Enphase Care premium support program for solar and battery systems. This service provides proactive monitoring, warranty support, and no-cost repair visits, enhancing customer confidence and extending the company's long-term relationship with clients. Enphase expects to e…
Intuitive Machines announced a new contract to build two IM 300 series spacecraft platforms for an undisclosed new customer. The IM 300 is a versatile and modular satellite platform designed for multiple mission types and payloads, produced at their high-volume Palo Alto facility. This order indicates growing demand across commercial, civil, and na…
Legend Biotech announced that interim CEO Alan Bash will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on September 15, 2026. The event aims to provide insights into the company's advancements in cell therapy, particularly regarding their CAR-T treatment for multiple myeloma, CARVYKTI.
Voyager Therapeutics, a biotechnology company focused on genetic treatments for neurological disorders, announced participation in several upcoming investor conferences including Wells Fargo, Cantor, Morgan Stanley, Baird, and H.C. Wainwright. The company will hold multiple fireside chats to discuss its pipeline and partnerships, with a webcast ava…
Nurix Therapeutics, a clinical-stage biopharmaceutical company focusing on targeted protein degradation therapies, announced that its management will participate in several upcoming investor conferences in September 2026, including those hosted by Wells Fargo, C. Wainwright, Baird, and Morgan Stanley. These events will feature fireside chats that w…
Rezolve Ai PLC reported an extraordinary 1,970% revenue increase to $130.8 million in H1 2026, driven by expanded customer base and robust partner-led distribution with Microsoft, Google, TCS, and Tech Mahindra. The company’s proprietary AI commerce infrastructure technology received critical validation through Google's infrastructure-level deploym…
CDT Equity Inc. appointed co-founder James Bligh as CEO to lead its next growth phase following several strategic developments including balance sheet strengthening and a key investment in quantum signature intelligence company Sarborg. Bligh’s background in public markets and finance is expected to guide CDT's focus on science-driven asset develop…
Daxor Corporation, a Nasdaq-listed medical diagnostics company specializing in precise blood volume measurement technology, delivered a mid-year corporate update highlighting its financial strength, commercial expansion with new sales leadership, manufacturing capacity investments, and ongoing clinical validation supporting its innovative next-gene…
ProMIS Neurosciences Inc., a clinical-stage biotech developing antibody therapeutics for neurodegenerative diseases, announced participation in several key investor and healthcare conferences throughout September 2026. The company will present updates on its EpiSelect™ platform and lead candidate PMN310, currently in an ongoing Phase 1b trial for e…
22nd Century Group, a Nasdaq-listed leader in low-nicotine tobacco products, reports accelerating growth with expanded retail presence from 2,000 to an expected 5,000 outlets by year-end 2026, improved gross margins driven by branded products, and consistent monthly sales growth. The company remains focused on commercial execution and innovation, l…
Wetour Robotics Limited has demonstrated its Orchestra system, integrating surface electromyography (sEMG) wristband data with first-person vision to overcome limitations of vision-only robot training. The fusion of muscle activation data with visual input enables more accurate capture of hand movement and force, even during occlusions, improving d…
BIO-key International, a leader in biometric identity and access management solutions, announced that CEO Michael DePasquale will participate in virtual meetings and present at the H.C. Wainwright Global Investment Conference in September 2026. The company's presentation will be available on demand to registered attendees, highlighting its biometri…
Emergent BioSolutions has been awarded a $24 million contract modification by BARDA, part of the U.S. Department of Health and Human Services, to supply its CYFENDUS® anthrax vaccine. This contract supports the U.S. government's ongoing anthrax preparedness efforts amid biological threats. CYFENDUS®, FDA-approved in 2023 for post-exposure prophylax…
Domino's shares have pulled back into the low $300s after a rough summer for restaurant stocks. The business still generates strong free cash flow ($653m last reported year), pays a 2.16% dividend and trades below historical multiples. Management's self-help initiatives (menu/marketing, digital execution and international expansion) plus a valuatio…
3 E Network Technology Group Limited announced that its wholly owned subsidiary secured a $1.2 million sales order for enterprise-grade DDR4 memory chips. This order demonstrates the company's capabilities in hardware supply amid growing IT infrastructure upgrades and provides additional revenue to support its AI infrastructure R&D efforts. The ord…
Sezzle Inc. announced that Gymshark, Debenhams Group (including its multiple brands), and Follett Higher Education are now offering Sezzle as a payment option at checkout. This expansion comes during a record back-to-school shopping season, providing flexible payment solutions for budget-conscious students and families. With Sezzle's point-of-sale …
Kayne Anderson Energy Infrastructure Fund, Inc. declared a monthly distribution of $0.09 per common share payable on September 30, 2026. The fund focuses on energy infrastructure securities and aims to provide high after-tax returns with an emphasis on cash distributions. Distribution amounts may vary and are subject to Board approval and financial…
Heidmar Maritime Holdings Corp. reported robust second quarter and first half 2026 results with total revenues of $29.0 million in Q2, a significant increase from $9.6 million in Q2 2025, driven by growth in commercially managed vessels and higher chartering activity. Net income attributable to shareholders rose to $2.2 million in Q2 2026 compared …
Kala Bio and Virotek announced a letter of intent to establish an exclusive U.S. distribution partnership where Kala will market and distribute Virotek's genetic testing program for ophthalmology. This collaboration aligns with Kala's strategic focus on eye care and provides a near-term commercial revenue opportunity while extending Kala's reach in…
NorthStrive Biosciences, a subsidiary of PMGC Holdings (NASDAQ: ELAB), announced an expanded three-phase program with Yuva Biosciences to advance four AI-discovered compounds toward lead nomination for developing potential therapies in cardiac diseases and obesity. The program builds upon positive Phase III results and aims to de-risk and narrow ca…
